THB 19.60+THB 0.00 (0.0%)
Bangkok Dusit Medical Services Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 12.5% below the high.
Loading market information…
SET · MEGA-R.BK · THB
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:37 AM UTC. Cached market data; not a live quote.
One-year closing-price history · THB. Historical prices are not a forecast.
Mega Lifesciences Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 17.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Mega Lifesciences Public Company Limited’s forward annual dividend is THB 1.70 per share, paid semi-annual. The forward yield is 5.15% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Mega Lifesciences Public Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Mega Lifesciences Public Company Limited, a subsidiary of Unistretch Limited, was founded in 1982 and is based in Bangkok, Thailand. This diversified healthcare enterprise is primarily involved in the production, promotion, and sale of an extensive array of health-related products, encompassing dietary supplements, over-the-counter (OTC) and prescription pharmaceuticals, herbal remedies, vitamins, and fast-moving consumer goods. The company organizes its activities across three main divisions: Brands, Distribution, and Original Equipment Manufacture (OEM). Its vast product portfolio includes a wide selection of complementary medicines designed for various needs, such as bone and joint support, children's health, diabetes and heart care, herbal solutions, liver and digestive well-being, skin health, weight management, overall vitality, specific men's and women's health products, and sports nutrition. Additionally, the pharmaceutical segment provides OTC solutions for gastrointestinal issues and pain, alongside a comprehensive range of prescription drugs targeting therapeutic areas like iron deficiency, anticoagulation, diabetology, cardiology, dermatology, gastroenterology, neurology, pain management, osteoporosis, respiratory conditions, urology, oncology, and nephrology. Beyond its core product lines, Mega Lifesciences offers logistical and marketing services for goods manufactured by other companies. It also operates wellness centers and engages in software design, development, and related service provisions. The company maintains a strong global footprint, with operations spanning the Asia Pacific, the Middle East, Africa, and the Commonwealth of Independent States regions.
Latest available per-share figures in THB. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:44 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| THB 3.21B-2.86% vs estimate |
| Q4 2024 | Feb 24, 2025 | THB 0.73+9.45% vs estimate | THB 3.66B-5.89% vs estimate |
|---|
| Q3 2024 | Nov 12, 2024 | THB 0.44+6.02% vs estimate | THB 4.00B+6.49% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
THB 19.60+THB 0.00 (0.0%)
Bangkok Dusit Medical Services Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 12.5% below the high.
THB 203.00+THB 6.50 (+3.31%)
Bumrungrad Hospital Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 5.14% below the high.
THB 10.80-THB 0.10 (-0.92%)
Bangkok Chain Hospital Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 10.74% below the high.
THB 4.84THB 0.00 (0.0%)
Inter Pharma Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 14.34% below the high.
THB 4.34-THB 0.04 (-0.91%)
Specialty Natural Products Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 11.79% below the high.
THB 2.48THB 0.00 (0.0%)
Asian Phytoceuticals Public Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.0% below the high.
THB 4.46-THB 0.02 (-0.45%)
Healthlead Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 42.08% below the high.
THB 0.76THB 0.00 (0.0%)
DOD Biotech Public Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 63.11% below the high.